Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Guo, Wenna ^a   Wang, Qiang ^b   Zhan, Yueping ^a   Chen, Xijia ^a   Yu, Qi ^c   Zhang, Jiawei ^d   Wang, Yi ^a   Xu, Xin Jian ^a   Zhu, Liucun ^a  

^a SHANGHAI UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^d Shanghai Sanda University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; MIRN191 MICRORNA, HUMAN; TRANSCRIPTOME; TUMOR MARKER;

ADULT; AGED; BREAST TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MALE; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE; PROGNOSIS; SEQUENCE ANALYSIS; THEORETICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BIOMARKERS, TUMOR; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MODELS, THEORETICAL; PROGNOSIS; RNA, LONG NONCODING; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84975789690     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27931     Document Type: Article

References (43)

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J Clin 63, 11-30, doi: 10.3322/caac.21166 (2013).
2. Borcherding, D. C. et al. Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer. Oncogene, doi: 10.1038/onc.2015.369 (2015).
3. Michaelson, J. S. et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer 95, 713-723, doi: 10.1002/cncr.10742 (2002).
4. Rakha, E. A. et al. Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 111, 121-127, doi: 10.1007/s10549-007-9768-4 (2008).
5. Shokouh, T. Z., Ezatollah, A. & Barand, P. Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study. Medicine 94, e1359, doi: 10.1097/MD.0000000000001359 (2015).
6. Ma, J. et al. AKR1B10 overexpression in breast cancer: Association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker. Int J Cancer 131, E862-871, doi: 10.1002/ijc.27618 (2012).
7. Crabb, S. J. et al. Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study. Breast Cancer Res 10, R6, doi: 10.1186/bcr1847 (2008).
8. Luporsi, E. et al. Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: Analytical and critical review. Breast Cancer Res Treat 132, 895-915, doi: 10.1007/s10549-011-1837-z (2012).
9. Kaufmann, M., Pusztai, L. & Biedenkopf Expert Panel, M. Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel. Cancer 117, 1575-1582, doi: 10.1002/cncr.25660 (2011).
10. Meng, J., Li, P., Zhang, Q., Yang, Z. & Fu, S. A four-long non-coding RNA signature in predicting breast cancer survival. J Exp Clin Cancer Res 33, 84, doi: 10.1186/s13046-014-0084-7 (2014).
11. Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076, doi: 10.1038/nature08975 (2010).
12. Zhou, X. et al. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. Sci Rep 5, 15972, doi: 10.1038/srep15972 (2015).
13. Peng, W., Wu, G., Fan, H., Wu, J. & Feng, J. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer. Tumour Biol 36, 6751-6758, doi: 10.1007/s13277-015-3376-4 (2015).
14. Gao, J. Z., Li, J., Du, J. L. & Li, X. L. Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrence. Oncol Lett 11, 1791-1798, doi: 10.3892/ol.2016.4130 (2016).
15. Zhang, J., Zhu, N. & Chen, X. A novel long noncoding RNA LINC01133 is upregulated in lung squamous cell cancer and predicts survival. Tumour Biol 36, 7465-7471, doi: 10.1007/s13277-015-3460-9 (2015).
16. Chin, L., Andersen, J. N. & Futreal, P. A. Cancer genomics: from discovery science to personalized medicine. Nat Med 17, 297-303, doi: 10.1038/nm.2323 (2011).
17. Koboldt, D. C., F. R., McLellan, M. D. & Schmidt, H. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70, doi: 10.1038/nature11412 (2012).
18. Johann, D. J., Jr. et al. Clinical proteomics and biomarker discovery. Ann N Y Acad Sci 1022, 295-305, doi: 10.1196/annals.1318.045 (2004).
19. Sundara Rajan, S., Hanby, A. M., Horgan, K., Thygesen, H. H. & Speirs, V. The potential utility of geminin as a predictive biomarker in breast cancer. Breast Cancer Res Treat 143, 91-98, doi: 10.1007/s10549-013-2786-5 (2014).
20. Sorensen, K. P. et al. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptorpositive primary breast cancer. Breast Cancer Res Treat 142, 529-536, doi: 10.1007/s10549-013-2776-7 (2013).
21. Yang, Y. F. et al. Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients. Med Oncol 31, 214, doi: 10.1007/s12032-014-0214-2 (2014).
22. Clarke, C. et al. Correlating transcriptional networks to breast cancer survival: A large-scale coexpression analysis. Carcinogenesis 34, 2300-2308, doi: 10.1093/carcin/bgt208 (2013).
23. Fredholm, H. et al. Breast cancer in young women: poor survival despite intensive treatment. PloS one 4, e7695, doi: 10.1371/journal. pone.0007695 (2009).
24. Xia, T. et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep 4, 6088, doi: 10.1038/srep06088 (2014).
25. Li, X. X. et al. Reduced expression levels of let-7c in human breast cancer patients. Oncol Lett 9, 1207-1212, doi: 10.3892/ol.2015.2877 (2015).
26. Khan, S. et al. miR-379 regulates cyclin B1 expression and is decreased in breast cancer. PloS one 8, e68753, doi: 10.1371/journal. pone.0068753 (2013).
27. Liu, J. et al. Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res 25, 46-54, doi: 10.3978/j.issn.1000-9604.2012.11.04 (2013).
28. Wang, B., Li, J., Sun, M., Sun, L. & Zhang, X. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. IUBMB life 66, 371-377, doi: 10.1002/iub.1273 (2014).
29. Margolin, A. A. et al. Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer. Sci Transl Med 5, 181re181, doi: 10.1126/scitranslmed.3006112 (2013).
30. Gwak, J. M. et al. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res Treat 147, 39-49, doi: 10.1007/s10549-014-3069-5 (2014).
31. Krutilina, R. et al. MicroRNA-18a inhibits hypoxia-inducible factor 1alpha activity and lung metastasis in basal breast cancers. Breast Cancer Res 16, R78, doi: 10.1186/bcr3693 (2014).
32. Dutertre, M. et al. Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer. Cancer Res 70, 3760-3770, doi: 10.1158/0008-5472.CAN-09-3988 (2010).
33. Cesana, M. et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358-369, doi: 10.1016/j.cell.2011.09.028 (2011).
34. Zou, A. E. et al. Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma. Rna 21, 1122-1134, doi: 10.1261/rna.049262.114 (2015).
35. Hu, Z. et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28, 1721-1726, doi: 10.1200/JCO.2009.24.9342 (2010).
36. Tammaro, C., Raponi, M., Wilson, D. I. & Baralle, D. BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer. Biochem Soc Trans 40, 768-772, doi: 10.1042/BST20120140 (2012).
37. Li, J. et al. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut 63, 1700-1710, doi: 10.1136/gutjnl-2013-305806 (2014).
38. Zhang, Y. C. et al. Genome-wide screening and functional analysis identify a large number of long noncoding RNAs involved in the sexual reproduction of rice. Genome Biol 15, 512, doi: 10.1186/s13059-014-0512-1 (2014).
39. Slyper, M. et al. Control of breast cancer growth and initiation by the stem cell-Associated transcription factor TCF3. Cancer Res 72, 5613-5624, doi: 10.1158/0008-5472.CAN-12-0119 (2012).
40. Iyer, M. K. et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Med 47, 199-208, doi: 10.1038/ng.3192 (2015).
41. Kadara, H. et al. A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis. Clin Cancer Res 17, 1490-1501, doi: 10.1158/1078-0432.CCR-10-2703 (2011).
42. Guo, L., Zhao, Y., Yang, S., Zhang, H. & Chen, F. An integrated analysis of miRNA, lncRNA, and mRNA expression profiles. Biomed Res Int 2014, 345605, doi: 10.1155/2014/345605 (2014).
43. Szklarczyk, D. et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43, D447-452, doi: 10.1093/nar/gku1003 (2015).